Todos Medical Ltd. (OTCQB: TOMDF) an Israeli company headquartered in Rehovot, is a cancer in-vitro-diagnostic (“IVD”) company developing a series of blood tests for the early detection of a variety of cancers. Our new cancer tests will add a layer to currently available cancer screening and diagnostics. Our goal is to help save lives through early detection while being minimally invasive to the patient.
The Israel-based company believes blood-based tests are the future of cancer screening, while sales of its coronavirus testing solutions continue to surge
Shareholders and others will have the opportunity to engage with top management from Biocept, Starton Therapeutics, Todos Medical, and Gevo
Director Interviews
Todos Medical receives a $3.4 million strategic investment from Yozma Group Korea
Director Interviews
Todos Medical forms distribution agreement with coronavirus immunity-focused Aditx Therapeutics
